CN Patent

CN105358535A — 恩杂鲁胺制剂

Assigned to Maddie Wilson LLC · Expires 2016-02-24 · 10y expired

What this patent protects

本发明提供恩杂鲁胺制剂及其治疗过度增殖性疾病的用途。

USPTO Abstract

本发明提供恩杂鲁胺制剂及其治疗过度增殖性疾病的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105358535A
Jurisdiction
CN
Classification
—
Expires
2016-02-24
Drug substance claim
No
Drug product claim
No
Assignee
Maddie Wilson LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.